FDA Device recall Z-1785-2019
Liquid Cardiac Control, Model Nos
- FDA Device
- Class II
- terminated
- Published 2019-06-26
On 2019-06-26 the FDA classified a Class II recall of Liquid Cardiac Control, Model Nos by Randox Laboratories, citing customers may observe a decrease in recovered concentration with regards to NTproBNP in the Liquid Cardiac Control lots identified, on the Siemens Dimension EXL LOCI.
Read the official FDA Device notice
| Agency | FDA Device |
|---|---|
| Recall number | Z-1785-2019 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2019-03-11 |
| Published | 2019-06-26 |
| Last updated | 2026-09-13 11:55 UTC |
| Company | Randox Laboratories |
| Distribution | CA, DE, PR, WV |
Product
Liquid Cardiac Control, Model Nos. CQ5051, CQ5052, CQ5053
Reason
Customers may observe a decrease in recovered concentration with regards to NTproBNP in the Liquid Cardiac Control lots identified, on the Siemens Dimension EXL LOCI.
Identifiers
| code_info | lots 4243CK, 4244CK, 4245CK. |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:55 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1785-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.